Advertisement
Coronavirus: Hong Kong panel holds off on recommending mainland China’s Sinovac vaccine for city’s free Covid-19 jabs programme
- Advisory group’s chairman Professor Wallace Lau releases update after it discusses latest clinical data
- Panel believes vaccine is safe but questions remain over when second dose is needed
Reading Time:3 minutes
Why you can trust SCMP
43
Hong Kong wants more information on the Covid-19 vaccines produced by Sinovac, before recommending the mainland China provider’s doses be used in the city’s free jabs programme.
Despite believing the vaccine to be safe, the city’s advisory panel still had questions after a three-hour discussion on Wednesday over new data provided by the Coronavac manufacturer.
Panel chairman Professor Wallace Lau Chak-sing said the group would meet again in two weeks’ time.
Advertisement
“After a long discussion, we believe the vaccine is safe and effective according to its data in the first and second stages,” Lau said.
01:10
Macau starts using China’s Sinopharm’s Covid-19 vaccine despite a lack of Phase 3 clinical data
Macau starts using China’s Sinopharm’s Covid-19 vaccine despite a lack of Phase 3 clinical data
Lau also said the panel had assessed phase-three clinical trials of the vaccines in Brazil, Turkey, and Indonesia and was satisfied with its effectiveness.
Advertisement
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x